Board of Neogen Chemicals to consider fund raising
On 08 December 2021The board of Neogen Chemicals will meet on 08 December 2021 to consider and approved the proposal for raising of funds by way of issue of any instrument or security(ies) including equity shares, fully/ partly convertible/ nonconvertible instruments including debenture warrants, and warrants entitling the warrant holder(s) to apply for equity shares or any other equity based instruments or eligible securities or any combination thereof in one or more tranche including by way of a public issue, qualified institution placements, preferential issue or a private placement.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
First Published: Mon, December 06 2021. 09:49 IST